Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

LTS Nutraceuticals, Inc. (LTSN) Broadens Product Reach In U.S. Market

Located in Ft. Lauderdale, Florida, LTS Nutraceuticals is a developer, manufacturer, and distributer of high-quality vitamins and dietary supplements. Today, the young company took a major step towards prominence with the announcement their BioCalth product, which is well-known across Asia, will now be sold on and

BioCalth is a unique, patented Calcium L-Thronate supplement that is scientifically proven to improve bone density and encourage the formulation of cartilage and collagen to strengthen bones. BioCalth is currently sold in some of the largest drug store chains in Asia, including Watson's, Unity and Guardian, as well as in Europe.

Ted Farnsworth, whom serves as Chairman of LTS stated in reference to this press release, "The bone and joint health supplements market continues to rise due to the growing aging population here in the U.S. and we believe BioCalth is unlike any supplement out there in the marketplace today. We are excited that these retailers also sees the potential of BioCalth in the U.S. market and we look forward to what we believe will be a successful brand for many years to come."

Currently, LTS Nutraceuticals, Inc. is trading in the $0.46 range. To learn more about the company as a whole, visit their corporate website at

Please see disclaimer on the QualityStocks website: